Results 41 to 50 of about 5,573 (260)

Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study, Bosphorus Retina Study Group Report No: 1 [PDF]

open access: yesTürk Oftalmoloji Dergisi, 2018
Objectives: To evaluate the real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in neovascular age-related macular degeneration (nAMD) patients.
Abdullah Özkaya   +23 more
doaj   +1 more source

Practical Considerations of PRN Medicines Management: An Integrative Systematic Review

open access: yesFrontiers in Pharmacology, 2022
Background and objectives: Highly widespread use of pro re nata (PRN) medicines in various healthcare settings is a potential area for improper medication prescription and administration leading to patient harm.
Abbas Mardani   +5 more
doaj   +1 more source

Paracetamol pro re nata orders: An audit

open access: yesJournal of Paediatrics and Child Health, 2004
Objectives:  Paracetamol is used widely in hospital practice, but little is known of the details concerning prescribing practices. This study compared the prescribing habits of physicians with regard to paracetamol, pro re nata (PRN), with the nursing interpretation of the order and with evidence‐based practice.Methods:  The charts of 313 children were
Lamb, SA, Henry, RL
openaire   +3 more sources

Progress of Diabetic Macular Edema after Loading Injection of Anti-Vascular Endothelial Growth Factor Agents in Real-World Cases

open access: yesMedicina, 2022
Background and Objectives: To evaluate the recurrence of diabetic macular edema (DME) after loading an injection of anti-VEGF agents by a pro re nata (PRN) protocol using central retinal thickness (CRT) as a re-injection criterion. Materials and Methods:
Hiroko Enomoto   +3 more
doaj   +1 more source

Ethical Tenets of PRN Medicines Management in Healthcare Settings: A Clinical Perspective

open access: yesPharmacy, 2021
Prescription and administration of pro re nata (PRN) medications has remained a poorly discussed area of the international literature regarding ethical tenets influencing this type of medication practice.
Mojtaba Vaismoradi   +3 more
doaj   +1 more source

Comparison of two different treatment regimens’ efficacy in neovascular age-related macular degeneration in Turkish population—based on real life data-Bosphorus RWE Study Group [PDF]

open access: yesInternational Journal of Ophthalmology, 2020
AIM: To compare two different anti-vascular endothelial growth factor (anti-VEGF) treatment regimens’-a priori pro re nata (PRN) and PRN regimen following the loading phase-anatomical and functional results in neovascular age-related macular degeneration
Burak Erden   +16 more
doaj   +1 more source

Clinical preferences and trends of anti‐vascular endothelial growth factor treatments for diabetic macular edema in Japan

open access: yesJournal of Diabetes Investigation, 2019
Aims/Introduction To determine the current clinical preferences of anti‐vascular endothelial growth factor (VEGF) treatment protocols for diabetic macular edema (DME) in Japan. Materials and Methods This was a descriptive cross‐sectional study.
Masahiko Sugimoto   +19 more
doaj   +1 more source

Safety and Effectiveness of Cataract Surgery with Simultaneous Intravitreal Anti-VEGF in Patients with Previously Treated Exudative Age-Related Macular Degeneration

open access: yesActa Médica Portuguesa, 2017
Introduction: To evaluate the safety and impact on visual acuity, retinal and choroidal morphology of simultaneous cataract surgery and intravitreal anti-vascular endothelial growth factor on patients with visually significant cataracts and previously ...
Manuel Sousa Falcão   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy